JTCS Click here to go to SJM website.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Hao Zhang
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, H.
Right arrow Articles by Hu, S.-S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Zhang, H.
Right arrow Articles by Hu, S.-S.
Related Collections
Right arrow Myocardial infarction

J Thorac Cardiovasc Surg 2009;137:216-222
© 2009 The American Association for Thoracic Surgery


Cardiopulmonary Support and Physiology

Intramyocardial injection of tannic acid attenuates postinfarction remodeling: A novel approach to stabilize the breaking extracellular matrix

Hao Zhang, MD, PhDa,b, Shen-jun Zhu, MDa, De Wang, MD, PhDa, Ying-jie Wei, PhDa, Sheng-Shou Hu, MDa,b,*

a Research Center for Cardiac Regenerative Medicine, the Ministry of Health, Cardiovascular Institute and Fu Wai Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China
b Department of Cardiac Surgery, Cardiovascular Institute and Fu Wai Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China

Received for publication January 18, 2008; revisions received June 10, 2008; accepted for publication July 6, 2008.

* Address for reprints: Sheng-Shou Hu, MD, Cardiovascular Institute and Fu Wai Hospital, Chinese Academy of Medical Science, Department of Cardiac Surgery, Beilishilu Rd 167A, Beijing 100037, P.R. China. (Email: shengshouhu{at}yahoo.com).

Objective: Myocardial infarction is associated with early matrix metalloproteinase activation and extracellular matrix degradation. We tested the hypothesis that stabilizing the original extracellular matrix of the infarcted left ventricle with local injection of tannic acid would preserve cardiac structure and function.

Methods: In vitro cytotoxicity of tannic acid was performed first; myocardial infarction model was induced by ligation of the left anterior descending branch in rats. Tannic acid was intramyocardially injected into infarcted site 24 hours after myocardial infarction (n = 30), and saline solution was injected in the same way as in the control (n = 30). The matrix metalloproteinase activity from tannic acid/saline solution–treated tissues was assayed by gelatin zymography 24 hours and 1 week after the treatment. The collagen content in the infarcted area was evaluated by hydroxyproline colorimetry assay 1 and 4 weeks after the treatment. Left ventricular structure and function were also evaluated with echocardiography, hemodynamics, and histologic examination.

Results: Tannic acid at a concentration of 0.05% had minimal cytotoxic effects on cultured cardiomyocytes and thus was subsequently chosen as the optimal concentration for injection. Compared with the saline solution injection group, tannic acid treatment inhibited the matrix metalloproteinase-2/-9 activity and increased the collagen content at the early post–myocardial infarction stage (48.6 ± 7.2 vs 37.3 ± 6 µg/mg dry weight). Tannic acid treatment also significantly reduced infarct expansion (infarct expansion index: 1.04 ± 0.15 vs 1.42 ± 0.21) and left ventricular dilatation at 4 weeks after infarction. Although tannic acid treatment improved fractional shortening (26% ± 2.4% vs 23.3% ± 3.2%), it failed to alter blood pressure (systolic blood pressure: 93.8 ± 8.2 vs 90.6 ± 8.5 mm Hg) and rate of pressure rise.

Conclusions: Local delivery of tannic acid prevents collagen matrix degradation via cross-linking fibrous collagen and inhibiting matrix metalloproteinase activity but does not improve the intrinsic contractile function of myocardium. This treatment may be helpful to attenuate the adverse topographic remodeling after acute myocardial infarction.



Abbreviations and Acronyms DMEM = Dulbecco's modified Eagle medium; ECM = extracellular matrix; EDD = end-diastolic dimensions; ESD = end-systolic dimensions; FS = fractional shortening; LV = left ventricular; MI = myocardial infarction; MMP = matrix metalloproteinase; MTT = 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide; OCT = optimum cutting temperature; PBS = phosphate-buffered saline solution; SD = Sprague-Dawley; TA = tannic acid; TIMP-2 = tissue inhibitor of metalloproteinase-2








HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2009 by The American Association for Thoracic Surgery.